Skip to content
Cultural Foundation
Author:
Sight Sciences, Inc.
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
October 1, 2026
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
September 1, 2026
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
August 19, 2026
Sight Sciences Reports Second Quarter 2026 Financial Results
August 5, 2026
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems
August 5, 2026
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System
August 4, 2026
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
May 6, 2026
Sight Sciences to Present at Two Upcoming Investor Conferences
April 29, 2026
Sight Sciences Announces the Release of its Sustainability Report
April 22, 2026
1
2
Next Page
→